Access the full text.
Sign up today, get DeepDyve free for 14 days.
G. Chinetti, C. Zawadski, J. Fruchart, B. Staels (2004)
Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARα, PPARγ, and LXRBiochemical and Biophysical Research Communications, 314
W.-S. Yang, M. Chen, W.-J. Lee, K-C Lee, Chia-Ling Chao, K. Huang, C-L Chen, T. Tai, L. Chuang (2003)
Adiponectin mRNA levels in the abdominal adipose depots of nondiabetic womenInternational Journal of Obesity, 27
Joseph Yu, S. Javorschi, A. Hevener, Y. Kruszynska, R. Norman, M. Sinha, J. Olefsky (2002)
The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects.Diabetes, 51 10
N. Kubota, Y. Terauchi, T. Yamauchi, Tetsuya Kubota, M. Moroi, J. Matsui, K. Eto, Tokuyuki Yamashita, J. Kamon, H. Satoh, Wataru Yano, P. Froguel, R. Nagai, S. Kimura, T. Kadowaki, T. Noda (2002)
Disruption of Adiponectin Causes Insulin Resistance and Neointimal Formation*The Journal of Biological Chemistry, 277
U. Tietge, K. Böker, M. Manns, M. Bahr (2004)
Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics.American journal of physiology. Endocrinology and metabolism, 287 1
M. Delporte, T. Funahashi, Masahiko Takahashi, Y. Matsuzawa, S. Brichard (2002)
Pre- and post-translational negative effect of beta-adrenoceptor agonists on adiponectin secretion: in vitro and in vivo studies.The Biochemical journal, 367 Pt 3
J. Hoffstedt, E. Arvidsson, E. Sjölin, K. Wåhlén, P. Arner (2004)
Adipose tissue adiponectin production and adiponectin serum concentration in human obesity and insulin resistance.The Journal of clinical endocrinology and metabolism, 89 3
T. Yamauchi, J. Kamon, H. Waki, Y. Imai, N. Shimozawa, K. Hioki, Shoko Uchida, Yusuke Ito, Keisuke Takakuwa, J. Matsui, M. Takata, K. Eto, Y. Terauchi, K. Komeda, M. Tsunoda, K. Murakami, Y. Ohnishi, T. Naitoh, K. Yamamura, Y. Ueyama, P. Froguel, S. Kimura, R. Nagai, T. Kadowaki (2003)
Globular Adiponectin Protected ob/ob Mice from Diabetes and ApoE-deficient Mice from Atherosclerosis*The Journal of Biological Chemistry, 278
A. Lihn, J. Bruun, G. He, S. Pedersen, P. Jensen, B. Richelsen (2004)
Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjectsMolecular and Cellular Endocrinology, 219
R. Lindsay, T. Funahashi, R. Hanson, Y. Matsuzawa, Sachiyo Tanaka, P. Tataranni, W. Knowler, J. Krakoff (2002)
Adiponectin and development of type 2 diabetes in the Pima Indian populationThe Lancet, 360
A. Berg, Terry Combs, Xueliang Du, M. Brownlee, P. Scherer (2001)
The adipocyte-secreted protein Acrp30 enhances hepatic insulin actionNature Medicine, 7
A. Kappes, G. Löffler (2000)
Influences of Ionomycin, Dibutyryl-cycloAMP and Tumour Necrosis Factor-alpha on Intracellular Amount and Secretion of apM1 in Differentiating Primary Human PreadipocytesHormone and Metabolic Research, 32
M. Fasshauer, J. Klein, S. Neumann, M. Eszlinger, R. Paschke (2001)
Adiponectin gene expression is inhibited by β‐adrenergic stimulation via protein kinase A in 3T3‐L1 adipocytesFEBS Letters, 507
T. Tsao, H. Murrey, C. Hug, David Lee, H. Lodish (2002)
Oligomerization State-dependent Activation of NF-κB Signaling Pathway by Adipocyte Complement-related Protein of 30 kDa (Acrp30)*The Journal of Biological Chemistry, 277
C. Halleux, Masahiko Takahashi, M. Delporte, R. Detry, T. Funahashi, Y. Matsuzawa, S. Brichard (2001)
Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue.Biochemical and biophysical research communications, 288 5
J. Fruebis, T. Tsao, S. Javorschi, D. Ebbets-reed, M. Erickson, F. Yen, B. Bihain, H. Lodish (2001)
Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice.Proceedings of the National Academy of Sciences of the United States of America, 98 4
Antonios Xydakis, C. Case, Peter Jones, R. Hoogeveen, Mine-Yine Liu, E. Smith, Kathleen Nelson, C. Ballantyne (2004)
Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction.The Journal of clinical endocrinology and metabolism, 89 6
J. Senn, P. Klover, I. Nowak, R. Mooney (2002)
Interleukin-6 induces cellular insulin resistance in hepatocytes.Diabetes, 51 12
J. Bogan, H. Lodish (1999)
Two Compartments for Insulin-Stimulated Exocytosis in 3t3-L1 Adipocytes Defined by Endogenous Acrp30 and Glut4The Journal of Cell Biology, 146
U. Pajvani, M. Hawkins, Terry Combs, Michael Rajala, T. Doebber, J. Berger, J. Wagner, Margaret Wu, Annemie Knopps, A. Xiang, K. Utzschneider, S. Kahn, J. Olefsky, T. Buchanan, P. Scherer (2004)
Complex Distribution, Not Absolute Amount of Adiponectin, Correlates with Thiazolidinedione-mediated Improvement in Insulin Sensitivity*Journal of Biological Chemistry, 279
P. Scherer, Suzanne Williams, M. Fogliano, G. Baldini, H. Lodish (1995)
A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes (*)The Journal of Biological Chemistry, 270
M. Faraj, P. Havel, Steve Phélis, D. Blank, A. Sniderman, K. Cianflone (2003)
Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects.The Journal of clinical endocrinology and metabolism, 88 4
H. Staiger, O. Tschritter, C. Kausch, R. Lammers, M. Stumvoll, Hans Häring (2002)
Human Serum Adiponectin Levels are not Under Short-Term Negative Control by Free Fatty Acids in VivoHormone and Metabolic Research, 34
F. Fisher, P. McTernan, G. Valsamakis, R. Chetty, A. Harte, A. Anwar, J. Starcynski, J. Crocker, A. Barnett, C. McTernan, S Kumar (2002)
Differences in adiponectin protein expression: effect of fat depots and type 2 diabetic status.Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 34 11-12
N. Maeda, Masahiko Takahashi, T. Funahashi, S. Kihara, H. Nishizawa, K. Kishida, H. Nagaretani, M. Matsuda, R. Komuro, N. Ouchi, H. Kuriyama, K. Hotta, Tadashi Nakamura, I. Shimomura, Y. Matsuzawa (2001)
PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein.Diabetes, 50 9
Elizabeth Bernstein, P. Koutkia, K. Ljungquist, J. Breu, B. Canavan, S. Grinspoon (2004)
Acute regulation of adiponectin by free fatty acids.Metabolism: clinical and experimental, 53 6
T. Pischon, C. Girman, G. Hotamisligil, N. Rifai, F. Hu, E. Rimm (2004)
Plasma adiponectin levels and risk of myocardial infarction in men.JAMA, 291 14
M. Cnop, M. Cnop, P. Havel, K. Utzschneider, Daniel Carr, M. Sinha, E. Boyko, B. Retzlaff, R. Knopp, J. Brunzell, S. Kahn (2003)
Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sexDiabetologia, 46
A. Carr, K. Samaras, S. Burton, M. Law, J. Freund, D. Chisholm, D. Cooper (1998)
A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitorsAIDS, 12
K. Hotta, T. Funahashi, Y. Arita, Masahiko Takahashi, M. Matsuda, Y. Okamoto, H. Iwahashi, H. Kuriyama, N. Ouchi, K. Maeda, M. Nishida, S. Kihara, N. Sakai, T. Nakajima, K. Hasegawa, M. Muraguchi, Y. Ohmoto, Tadashi Nakamura, S. Yamashita, T. Hanafusa, Y. Matsuzawa (2000)
Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.Arteriosclerosis, thrombosis, and vascular biology, 20 6
T. Yamauchi, J. Kamon, Y. Minokoshi, Yoichi Ito, H. Waki, S. Uchida, S. Yamashita, M. Noda, Shunbun Kita, K. Ueki, Koji Eto, Y. Akanuma, P. Froguel, F. Foufelle, P. Ferré, D. Carling, Shigeko Kimura, R. Nagai, B. Kahn, T. Kadowaki (2002)
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinaseNature Medicine, 8
J. Yudkin, C. Stehouwer, J. Emeis, S. Coppack (1999)
C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?Arteriosclerosis, thrombosis, and vascular biology, 19 4
A. Lihn, T. Østergård, B. Nyholm, S. Pedersen, B. Richelsen, O. Schmitz (2003)
Adiponectin expression in adipose tissue is reduced in first-degree relatives of type 2 diabetic patients.American journal of physiology. Endocrinology and metabolism, 284 2
W. Haque, I. Shimomura, Y. Matsuzawa, A. Garg (2004)
Serum adiponectin and leptin levels in patients with lipodystrophies.The Journal of clinical endocrinology and metabolism, 87 5
A. Berg, Terry Combs, P. Scherer (2002)
ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolismTrends in Endocrinology & Metabolism, 13
T. Yatagai, S. Nagasaka, A. Taniguchi, M. Fukushima, Tomoatsu Nakamura, A. Kuroe, Y. Nakai, S. Ishibashi (2003)
Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus.Metabolism: clinical and experimental, 52 10
Y. Matsuzawa, T. Funahashi, Tadashi Nakamura (1999)
Molecular Mechanism of Metabolic Syndrome X: Contribution of Adipocytokines · Adipocyte‐derived Bioactive SubstancesAnnals of the New York Academy of Sciences, 892
A. Gavrila, Chung-Kang Peng, J. Chan, J. Mietus, A. Goldberger, C. Mantzoros (2003)
Diurnal and ultradian dynamics of serum adiponectin in healthy men: comparison with leptin, circulating soluble leptin receptor, and cortisol patterns.The Journal of clinical endocrinology and metabolism, 88 6
Terry Combs, J. Wagner, J. Berger, T. Doebber, Wen-jun Wang, Bei Zhang, M. Tanen, A. Berg, S. O’Rahilly, D. Savage, K. Chatterjee, S. Weiss, P. Larson, K. Gottesdiener, B. Gertz, M. Charron, P. Scherer, D. Moller (2002)
Induction of Adipocyte Complement-Related Protein of 30 Kilodaltons by PPARγ Agonists: A Potential Mechanism of Insulin Sensitization.Endocrinology, 143 3
T. Yamauchi, J. Kamon, H. Waki, Y. Terauchi, N. Kubota, K. Hara, Y. Mori, T. Ide, K. Murakami, N. Tsuboyama-Kasaoka, O. Ezaki, Y. Akanuma, O. Gavrilova, C. Vinson, M. Reitman, H. Kagechika, K. Shudo, M. Yoda, Y. Nakano, K. Tobe, R. Nagai, Shigeko Kimura, Motowo Tomita, P. Froguel, T. Kadowaki (2001)
The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesityNature Medicine, 7
A. Xu, Yu Wang, H. Keshaw, L. Xu, K. Lam, G. Cooper (2003)
The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice.The Journal of clinical investigation, 112 1
T. Yamauchi, J. Kamon, Yusuke Ito, A. Tsuchida, T. Yokomizo, Shunbun Kita, T. Sugiyama, M. Miyagishi, K. Hara, M. Tsunoda, K. Murakami, T. Ohteki, Shoko Uchida, Sato Takekawa, H. Waki, N. Tsuno, Y. Shibata, Y. Terauchi, P. Froguel, K. Tobe, S. Koyasu, K. Taira, T. Kitamura, Takao Shimizu, R. Nagai, T. Kadowaki (2003)
Cloning of adiponectin receptors that mediate antidiabetic metabolic effectsNature, 423
Y. Arita, S. Kihara, N. Ouchi, Masahiko Takahashi, K. Maeda, J. Miyagawa, K. Hotta, I. Shimomura, Tadashi Nakamura, K. Miyaoka, H. Kuriyama, M. Nishida, S. Yamashita, K. Okubo, K. Matsubara, M. Muraguchi, Y. Ohmoto, T. Funahashi, Y. Matsuzawa (1999)
Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.Biochemical and biophysical research communications, 257 1
J. Altomonte, S. Harbaran, Anja Richter, Hengjiang Dong (2003)
Fat depot-specific expression of adiponectin is impaired in Zucker fatty rats.Metabolism: clinical and experimental, 52 8
Q. Tong, J. Sankalé, C. Hadigan, G. Tan, E. Rosenberg, P. Kanki, S. Grinspoon, G. Hotamışlıgil (2003)
Regulation of adiponectin in human immunodeficiency virus-infected patients: relationship to body composition and metabolic indices.The Journal of clinical endocrinology and metabolism, 88 4
P. Kern, S. Ranganathan, Chunling Li, Linda Wood, G. Ranganathan (2001)
Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance.American journal of physiology. Endocrinology and metabolism, 280 5
Yu Wang, A. Xu, Catriona Knight, L. Xu, G. Cooper (2002)
Hydroxylation and Glycosylation of the Four Conserved Lysine Residues in the Collagenous Domain of AdiponectinThe Journal of Biological Chemistry, 277
G. Hotamisligil (1999)
The role of TNFalpha and TNF receptors in obesity and insulin resistance.Journal of internal medicine, 245 6
TS Tsao, E Tomas, HE Murrey, C Hug, DH Lee, NB Ruderman, JE Heuser, HF Lodish (2003;)
Role of Disulfide Bonds in Acrp30/Adiponectin Structure and Signaling Specificity: different oligomers activate different signal transduction pathwaysJ Biol Chem, 278
C. Zoccali, F. Mallamaci, P. Finocchiaro (2002)
Atherosclerotic renal artery stenosis: epidemiology, cardiovascular outcomes, and clinical prediction rules.Journal of the American Society of Nephrology : JASN, 13 Suppl 3
C. Zoccali, F. Mallamaci, G. Tripepi, F. Benedetto, S. Cutrupi, S. Parlongo, L. Malatino, G. Bonanno, G. Seminara, F. Rapisarda, P. Fatuzzo, M. Buemi, G. Nicocia, Sachiyo Tanaka, N. Ouchi, S. Kihara, T. Funahashi, Y. Matsuzawa (2002)
Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease.Journal of the American Society of Nephrology : JASN, 13 1
J. Seidell, L. Pérusse, J. Despres, C. Bouchard (2001)
Waist and hip circumferences have independent and opposite effects on cardiovascular disease risk factors: the Quebec Family Study.The American journal of clinical nutrition, 74 3
Wei-Shiung Yang, Wei-Jei Lee, Tohru Funahashi, Sachiyo Tanaka, Yuji Matsuzawa, Chia-Ling Chao, Chi-Ling Chen, Tong-Yuan Tai, Lee-Ming Chuang (2001)
Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin.The Journal of clinical endocrinology and metabolism, 86 8
UB Pajvani, X Du, TP Combs, AH Berg, MW Rajala, T Schulthess, J Engel, M Brownlee, PE Scherer (2003;)
Structure‐function studies of the adipocyte‐secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivityJ Biol Chem, 278
M. Garaulet, N. Viguerie, S. Porubský, E. Klimčáková, K. Clément, D. Langin, V. Štich (2004)
Adiponectin gene expression and plasma values in obese women during very-low-calorie diet. Relationship with cardiovascular risk factors and insulin resistance.The Journal of clinical endocrinology and metabolism, 89 2
K. Hotta, T. Funahashi, N. Bodkin, H. Ortmeyer, Y. Arita, B. Hansen, Y. Matsuzawa (2001)
Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys.Diabetes, 50 5
A. Lihn, B. Richelsen, S. Pedersen, S. Haugaard, G. Rathje, S. Madsbad, O. Andersen (2003)
Increased expression of TNF-alpha, IL-6, and IL-8 in HALS: implications for reduced adiponectin expression and plasma levels.American journal of physiology. Endocrinology and metabolism, 285 5
Terry Combs, J. Wagner, J. Berger, T. Doebber, Wen-jun Wang, Bei Zhang, M. Tanen, A. Berg, S. O’Rahilly, D. Savage, K. Chatterjee, S. Weiss, P. Larson, K. Gottesdiener, B. Gertz, M. Charron, P. Scherer, D. Moller (2002)
Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization.Endocrinology, 143 3
P. Boudou, E. Sobngwi, F. Mauvais-Jarvis, P. Vexiau, J. Gautier (2003)
Absence of exercise-induced variations in adiponectin levels despite decreased abdominal adiposity and improved insulin sensitivity in type 2 diabetic men.European journal of endocrinology, 149 5
M. Fasshauer, J. Klein, S. Neumann, M. Eszlinger, R. Paschke (2002)
Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes.Biochemical and biophysical research communications, 290 3
Yong Qi, N. Takahashi, S. Hileman, H. Patel, A. Berg, U. Pajvani, P. Scherer, R. Ahima (2004)
Adiponectin acts in the brain to decrease body weightNature Medicine, 10
K. Ma, A. Cabrero, P. Saha, Hideto Kojima, Lan Li, B. Chang, A. Paul, L. Chan (2002)
Increased β-Oxidation but No Insulin Resistance or Glucose Intolerance in Mice Lacking Adiponectin*The Journal of Biological Chemistry, 277
N. Maeda, I. Shimomura, K. Kishida, H. Nishizawa, M. Matsuda, H. Nagaretani, N. Furuyama, H. Kondo, Masahiko Takahashi, Y. Arita, R. Komuro, N. Ouchi, S. Kihara, Y. Tochino, K. Okutomi, M. Horie, S. Takeda, T. Aoyama, T. Funahashi, Y. Matsuzawa (2002)
Diet-induced insulin resistance in mice lacking adiponectin/ACRP30Nature Medicine, 8
E. Brakenhielm, N. Veitonmäki, R. Cao, S. Kihara, Y. Matsuzawa, B. Zhivotovsky, T. Funahashi, Yihai Cao (2004)
Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis.Proceedings of the National Academy of Sciences of the United States of America, 101 8
(2005)
Implications of 20 Adiponectin, regulation and association to insulin sensitivity A
Yukihiro Yamamoto, H. Hirose, I. Saito, M. Tomita, M. Taniyama, K. Matsubara, Y. Okazaki, T. Ishii, K. Nishikai, T. Saruta (2002)
Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population.Clinical science, 103 2
E. Hu, P. Liang, B. Spiegelman (1996)
AdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity (*)The Journal of Biological Chemistry, 271
Yasuhiro Nakamura, K. Shimada, Daiju Fukuda, Y. Shimada, S. Ehara, Makoto Hirose, T. Kataoka, K. Kamimori, S. Shimodozono, Yoshiki Kobayashi, M. Yoshiyama, K. Takeuchi, J. Yoshikawa (2004)
Implications of plasma concentrations of adiponectin in patients with coronary artery diseaseHeart, 90
C. Weyer, T. Funahashi, Sachiyo Tanaka, K. Hotta, Y. Matsuzawa, R. Pratley, P. Tataranni (2001)
Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia.The Journal of clinical endocrinology and metabolism, 86 5
A. Comuzzie, T. Funahashi, G. Sonnenberg, L. Martin, H. Jacob, Anne Black, D. Maas, Masahiko Takahashi, S. Kihara, Sachiyo Tanaka, Y. Matsuzawa, J. Blangero, D. Cohen, A. Kissebah (2001)
The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome.The Journal of clinical endocrinology and metabolism, 86 9
H. Motoshima, Xiangdong Wu, M. Sinha, V. Hardy, E. Rosato, D. Barbot, F. Rosato, B. Goldstein (2002)
Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone.The Journal of clinical endocrinology and metabolism, 87 12
M. Hulver, J. Houmard, W. Kraus, W. Pories, K. Macdonald, And Dohm, D. Zheng, C. Tanner, C. Slentz, M. Sinha, G. Lynis, Dohm, W. Hulver (2002)
Adiponectin is not altered with exercise training despite enhanced insulin action.American journal of physiology. Endocrinology and metabolism, 283 4
Stith Rd, J. Luo (1994)
Endocrine and carbohydrate responses to interleukin-6 in vivo.Circulatory shock, 44 4
RS Ahima, JS Flier (2000;)
Adipose tissue as an endocrine organTrends Endocrinol Metab, 11
N. Ouchi, S. Kihara, Y. Arita, K. Maeda, H. Kuriyama, Y. Okamoto, K. Hotta, M. Nishida, Masahiko Takahashi, Tadashi Nakamura, S. Yamashita, T. Funahashi, Y. Matsuzawa (1999)
Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin.Circulation, 100 25
J. Spranger, A. Kroke, M. Möhlig, M. Bergmann, M. Ristow, H. Boeing, A. Pfeiffer (2003)
Adiponectin and protection against type 2 diabetes mellitusThe Lancet, 361
S. Phillips, T. Ciaraldi, A. Kong, R. Bandukwala, V. Aroda, L. Carter, S. Baxi, S. Mudaliar, R. Henry (2003)
Modulation of circulating and adipose tissue adiponectin levels by antidiabetic therapy.Diabetes, 52 3
H. Nishizawa, I. Shimomura, K. Kishida, N. Maeda, H. Kuriyama, H. Nagaretani, M. Matsuda, H. Kondo, N. Furuyama, S. Kihara, Tadashi Nakamura, Y. Tochino, T. Funahashi, Y. Matsuzawa (2002)
Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein.Diabetes, 51 9
Terry Combs, A. Berg, S. Obici, P. Scherer, L. Rossetti (2001)
Endogenous glucose production is inhibited by the adipose-derived protein Acrp30.The Journal of clinical investigation, 108 12
Terry Combs, U. Pajvani, A. Berg, Ying Lin, L. Jelicks, M. Laplante, A. Nawrocki, Michael Rajala, A. Parlow, Laurelle Cheeseboro, Yang-Yang Ding, R. Russell, D. Lindemann, Adam Hartley, G. Baker, S. Obici, Y. Deshaies, M. Ludgate, L. Rossetti, P. Scherer (2004)
A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity.Endocrinology, 145 1
I. Kharroubi, J. Rasschaert, D. Eizirik, M. Cnop (2003)
Expression of adiponectin receptors in pancreatic beta cells.Biochemical and biophysical research communications, 312 4
U. Pajvani, Xueliang Du, Terry Combs, A. Berg, Michael Rajala, T. Schulthess, J. Engel, M. Brownlee, P. Scherer (2003)
Structure-Function Studies of the Adipocyte-secreted Hormone Acrp30/AdiponectinThe Journal of Biological Chemistry, 278
G. Hotamisligil (1999)
The role of TNFα and TNF receptors in obesity and insulin resistanceJournal of Internal Medicine, 245
T. Tsao, E. Tomás, H. Murrey, C. Hug, David Lee, N. Ruderman, J. Heuser, H. Lodish (2003)
Role of Disulfide Bonds in Acrp30/Adiponectin Structure and Signaling SpecificityJournal of Biological Chemistry, 278
P. Kern, G. Gregorio, T. Lu, N. Rassouli, G. Ranganathan (2003)
Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression.Diabetes, 52 7
N. Ouchi, S. Kihara, T. Funahashi, Tadashi Nakamura, M. Nishida, M. Kumada, Y. Okamoto, K. Ohashi, H. Nagaretani, K. Kishida, H. Nishizawa, N. Maeda, Hideki Kobayashi, H. Hiraoka, Y. Matsuzawa (2003)
Reciprocal Association of C-Reactive Protein With Adiponectin in Blood Stream and Adipose TissueCirculation: Journal of the American Heart Association, 107
G. Chinetti, C. Zawadski, J. Fruchart, B. Staels (2004)
Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARalpha, PPARgamma, and LXR.Biochemical and biophysical research communications, 314 1
M. Matsubara, Shinji Katayose, S. Maruoka (2003)
Decreased plasma adiponectin concentrations in nondiabetic women with elevated homeostasis model assessment ratios.European journal of endocrinology, 148 3
A. Kissebah, G. Sonnenberg, Joel Myklebust, Michael Goldstein, K. Broman, Roland James, Jacqueline Marks, G. Krakower, H. Jacob, J. Weber, L. Martin, J. Blangero, A. Comuzzie (2000)
Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome.Proceedings of the National Academy of Sciences of the United States of America, 97 26
Adiponectin is a novel adipocyte‐specific protein, which, it has been suggested, plays a role in the development of insulin resistance and atherosclerosis. Although it circulates in high concentrations, adiponectin levels are lower in obese subjects than in lean subjects. Apart from negative correlations with measures of adiposity, adiponectin levels are also reduced in association with insulin resistance and type 2 diabetes. Visceral adiposity has been shown to be an independent negative predictor of adiponectin. Thus, most features of the metabolic syndrome's negative associations with adiponectin have been shown. Adiponectin levels seem to be reduced prior to the development of type 2 diabetes, and administration of adiponectin has been accompanied by lower plasma glucose levels as well as increased insulin sensitivity. Furthermore, reduced expression of adiponectin has been associated with some degree of insulin resistance in animal studies indicating a role for hypoadiponectinaemia in relation to insulin resistance. The primary mechanisms by which adiponectin enhance insulin sensitivity appears to be through increased fatty acid oxidation and inhibition of hepatic glucose production. Adiponectin levels are increased by thiazoledinedione treatment, and this effect might be important for the enhanced insulin sensitivity induced by thiazolidinediones. In contrast, adiponectin levels are reduced by pro‐inflammatory cytokines especially tumour necrosis factor‐α. In summary, adiponectin in addition to possible anti‐inflammatory and anti‐atherogenic effects appears to be an insulin enhancer, with potential as a new pharmacologic treatment modality of the metabolic syndrome and type 2 diabetes.
Obesity Reviews – Wiley
Published: Feb 1, 2005
Keywords: ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.